African Journal of
Pharmacy and Pharmacology

  • Abbreviation: Afr. J. Pharm. Pharmacol.
  • Language: English
  • ISSN: 1996-0816
  • DOI: 10.5897/AJPP
  • Start Year: 2007
  • Published Articles: 2226

Full Length Research Paper

Clinical pharmacists education and counselling in patients with co-morbid hypertension and diabetes in a Municipal hospital in Ghana

Kwakye A. O.
  • Kwakye A. O.
  • Department of Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Google Scholar
Buabeng K. O.
  • Buabeng K. O.
  • Department of Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Google Scholar
Opare-Addo N. A. M.
  • Opare-Addo N. A. M.
  • Department of Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Google Scholar
Owusu-Dabo E.
  • Owusu-Dabo E.
  • School of Public Health, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Google Scholar


  •  Received: 15 August 2021
  •  Accepted: 29 September 2021
  •  Published: 31 October 2021

References

Agyei-Mensah S, Aikins AD (2010). Epidemiological Transition and the Double Burden of Disease in Accra, Ghana. Journal of Urban Health 87(5):879-897.
Crossref

 

Alomar MJ (2014). Factors affecting the development of adverse drug reactions. Saudi Pharmaceutical Journal 22(2):83-94.
Crossref

 

Anderegg MD, Gums TH, Uribe L, MacLaughlin EJ, Hoehns J, Bazaldua OV, Ives TJ, Hahn DL, Coffey CS, Carter BL (2018). Pharmacist intervention for blood pressure control in patients with diabetes and/or chronic kidney disease. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38(3):309-18.
Crossref

 

Bajorek B, Lemay KS, Magin P, Roberts C, Krass I, Armour CL (2016). Implementation and evaluation of a pharmacist-led hypertension management service in primary care: outcomes and methodological challenges. Pharmacy Practice (Granada) 14(2):0-0.
Crossref

 

Chemello C, Souza FD, Patricio ED, Farias MR (2014). Pharmaceutical care as a strategy to improve the safety and effectiveness of patients' pharmacotherapy at a pharmacy school: a practical proposal. Brazilian Journal of Pharmaceutical Sciences 50:185-93.
Crossref

 

Cipolle RJ, Strand LM, Morley PC (2012). Pharmaceutical care practice: the patient-centered approach to medication management. McGraw Hill Professional pp. 1-5.

 

da Costa FA, Van Mil JF, Alvarez-Risco A (2019). The pharmacist guide to implementing pharmaceutical care. Springer International Publishing pp. 4-6.

 

De la Monte SM, Wands JR (2008). Alzheimer's disease is type 3 diabetes-evidence reviewed. Journal of Diabetes Science and Technology 2(6):1101-13.
Crossref

 

Dosoo DK, Nyame S, Enuameh Y, Ayetey H, Danwonno H, Twumasi M, Tabiri C, Gyaase S, Lip GY, Owusu-Agyei S, Asante KP (2019). Prevalence of hypertension in the middle belt of Ghana: a community-based screening study. International Journal of hypertension.
Crossref

 

Gatimu SM, Milimo BW, San Sebastian M (2016). Prevalence and determinants of diabetes among older adults in Ghana. BMC Public Health 16(1):1-2.
Crossref

 

Gouda HN, Charlson F, Sorsdahl K, Ahmadzada S, Ferrari AJ, Erskine H, Leung J, Santamauro D, Lund C, Aminde LN, Mayosi BM (2019). Burden of non-communicable diseases in sub-Saharan Africa, 1990-2017: results from the Global Burden of Disease Study 2017. The Lancet Global Health 7(10):e1375-87.
Crossref

 

Haghighatpanah M, Nejad ASM (2018). Factors that correlate with poor glycemic control in type 2 diabetes mellitus patients with complications. Osong public health and research perspectives 9(4):167.
Crossref

 

Hickey KT, Creber RM, Reading M, Sciacca RR, Riga TC, Frulla AP, Casida JM (2018). Low health literacy: Implications for managing cardiac patients in practice. The Nurse Practitioner 43(8):49.
Crossref

 

Kardas P, Lewek P, Matyjaszczyk M (2013). Determinants of patient adherence: a review of systematic reviews. Frontiers in pharmacology 4:91.
Crossref

 

Korcegez EI, Sancar M, Demirkan K (2017). Effect of a pharmacist-led program on improving outcomes in patients with type 2 diabetes mellitus from Northern Cyprus: a randomized controlled trial. Journal of Managed Care and Specialty Pharmacy 23(5):573-82.
Crossref

 

Marfo AF, Owusu-Daaku FT (2017). Exploring the extended role of the community pharmacist in improving blood pressure control among hypertensive patients in a developing setting. Journal of Pharmaceutical Policy and Practice 10(1):1-9.
Crossref

 

Muhammad A, Rahman NU, Saeed Ur Rashid N, Atif R, Humayun R, Misbah S, Saleha S (2018). Impact of pharmacist's intervention on disease related knowledge, medication adherence, HRQoL and control of blood pressure among hypertensive patients. Pakistan Journal of Pharmaceutical Sciences 31(6): 2607-2616.

 

Nogueira M, Otuyama LJ, Rocha PA, Pinto VB (2020). Pharmaceutical care-based interventions in type 2 diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials. Einstein (São Paulo) 18:eRW4686.
Crossref

 

Robinson JD, Segal R, Lopez LM, Doty RE (2010). Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice. Annals of Pharmacotherapy 44(1):88-96.
Crossref

 

Saleem F, Hassali MA, Shafie AA, Ul Haq N, Farooqui M, Aljadhay H, Ahmad FU (2015). Pharmacist intervention in improving hypertension?related knowledge, treatment medication adherence and health?related quality of life: a non?clinical randomized controlled trial. Health Expectations 18(5):1270-1281.
Crossref

 

Saqib A, Atif M, Ikram R, Riaz F, Abubakar M, Scahill S (2018). Factors affecting patients' knowledge about dispensed medicines: A Qualitative study of healthcare professionals and patients in Pakistan. PloS One 13(6): e0197482.
Crossref

 

Shao H, Chen G, Zhu C, Chen Y, Liu Y, He Y, Jin H (2017). Effect of pharmaceutical care on clinical outcomes of outpatients with type 2 diabetes mellitus. Patient Preference and Adherence 11:897-903.
Crossref

 

Skowron A, Polak S, Brandys J (2011). The impact of pharmaceutical care on patients with hypertension and their pharmacists. Pharmacy practice. 9(2):110.
Crossref

 

Sriram S, Chack LE, Ramasamy R, Ghasemi A, Ravi TK, Sabzghabaee AM (2011). Impact of pharmaceutical care on quality of life in patients with type 2 diabetes mellitus. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences 16(Suppl1): S412.

 

Tommelein E, Mehuys E, Van Hees T, Adriaens E, Van Bortel L, Christiaens T, Van Tongelen I, Remon JP, Boussery K, Brusselle G (2014). Effectiveness of pharmaceutical care for patients with chronic obstructive pulmonary disease (PHARMACOP): a randomized controlled trial. British Journal of Clinical Pharmacology 77(5):756-66.
Crossref

 

Whitson HE, Johnson KS, Sloane R, Cigolle CT, Pieper CF, Landerman L, Hastings SN (2016). Identifying patterns of multimorbidity in older Americans: application of latent class analysis. Journal of the American Geriatrics Society 64(8):1668-1673.
Crossref

 

World Health Organization (WHO) (2018). Noncommunicable diseases Country Profiles 2018.